50 related articles for article (PubMed ID: 27499454)
1. Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors.
Labadie SS; Dragovich PS; Cummings RT; Deshmukh G; Gustafson A; Han N; Harmange JC; Kiefer JR; Li Y; Liang J; Liederer BM; Liu Y; Manieri W; Mao W; Murray L; Ortwine DF; Trojer P; VanderPorten E; Vinogradova M; Wen L
Bioorg Med Chem Lett; 2016 Sep; 26(18):4492-4496. PubMed ID: 27499454
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.
Horton JR; Engstrom A; Zoeller EL; Liu X; Shanks JR; Zhang X; Johns MA; Vertino PM; Fu H; Cheng X
J Biol Chem; 2016 Feb; 291(6):2631-46. PubMed ID: 26645689
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds.
Horton JR; Liu X; Gale M; Wu L; Shanks JR; Zhang X; Webber PJ; Bell JSK; Kales SC; Mott BT; Rai G; Jansen DJ; Henderson MJ; Urban DJ; Hall MD; Simeonov A; Maloney DJ; Johns MA; Fu H; Jadhav A; Vertino PM; Yan Q; Cheng X
Cell Chem Biol; 2016 Jul; 23(7):769-781. PubMed ID: 27427228
[TBL] [Abstract][Full Text] [Related]
4. Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors.
Korczynska M; Le DD; Younger N; Gregori-Puigjané E; Tumber A; Krojer T; Velupillai S; Gileadi C; Nowak RP; Iwasa E; Pollock SB; Ortiz Torres I; Oppermann U; Shoichet BK; Fujimori DG
J Med Chem; 2016 Feb; 59(4):1580-98. PubMed ID: 26699912
[TBL] [Abstract][Full Text] [Related]
5. KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
Li CY; Wang W; Leung CH; Yang GJ; Chen J
Mol Cancer; 2024 May; 23(1):109. PubMed ID: 38769556
[TBL] [Abstract][Full Text] [Related]
6. Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5A.
Horton JR; Liu X; Wu L; Zhang K; Shanks J; Zhang X; Rai G; Mott BT; Jansen DJ; Kales SC; Henderson MJ; Pohida K; Fang Y; Hu X; Jadhav A; Maloney DJ; Hall MD; Simeonov A; Fu H; Vertino PM; Yan Q; Cheng X
J Med Chem; 2018 Apr; 61(7):3193-3208. PubMed ID: 29537847
[TBL] [Abstract][Full Text] [Related]
7. Solving the puzzle of fibrosis resolution in alcohol-associated liver disease: An insight from KDM5 demethylases and LXR activation.
Ma J; Liangpunsakul S
Hepatology; 2024 Feb; ():. PubMed ID: 38449427
[No Abstract] [Full Text] [Related]
8. From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.
Liang J; Labadie S; Zhang B; Ortwine DF; Patel S; Vinogradova M; Kiefer JR; Mauer T; Gehling VS; Harmange JC; Cummings R; Lai T; Liao J; Zheng X; Liu Y; Gustafson A; Van der Porten E; Mao W; Liederer BM; Deshmukh G; An L; Ran Y; Classon M; Trojer P; Dragovich PS; Murray L
Bioorg Med Chem Lett; 2017 Jul; 27(13):2974-2981. PubMed ID: 28512031
[TBL] [Abstract][Full Text] [Related]
9. Pyrido[3,4-d]pyrimidin-4(3H)-one metabolism mediated by aldehyde oxidase is blocked by C2-substitution.
Hayes A; Mok NY; Liu M; Thai C; Henley AT; Atrash B; Lanigan RM; Sejberg J; Le Bihan YV; Bavetsias V; Blagg J; Raynaud FI
Xenobiotica; 2017 Sep; 47(9):771-777. PubMed ID: 27618572
[TBL] [Abstract][Full Text] [Related]
10. Compounds and methods for inhibiting histone demethylases: a patent evaluation of US20160102096A1.
Thaler F; Mercurio C
Expert Opin Ther Pat; 2016 Dec; 26(12):1367-1370. PubMed ID: 27730846
[TBL] [Abstract][Full Text] [Related]
11. Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.
Tumber A; Nuzzi A; Hookway ES; Hatch SB; Velupillai S; Johansson C; Kawamura A; Savitsky P; Yapp C; Szykowska A; Wu N; Bountra C; Strain-Damerell C; Burgess-Brown NA; Ruda GF; Fedorov O; Munro S; England KS; Nowak RP; Schofield CJ; La Thangue NB; Pawlyn C; Davies F; Morgan G; Athanasou N; Müller S; Oppermann U; Brennan PE
Cell Chem Biol; 2017 Mar; 24(3):371-380. PubMed ID: 28262558
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.
Horton JR; Woodcock CB; Chen Q; Liu X; Zhang X; Shanks J; Rai G; Mott BT; Jansen DJ; Kales SC; Henderson MJ; Cyr M; Pohida K; Hu X; Shah P; Xu X; Jadhav A; Maloney DJ; Hall MD; Simeonov A; Fu H; Vertino PM; Cheng X
J Med Chem; 2018 Dec; 61(23):10588-10601. PubMed ID: 30392349
[TBL] [Abstract][Full Text] [Related]
13. ARID3a from the ARID family: structure, role in autoimmune diseases and drug discovery.
Guo CC; Xu HE; Ma X
Acta Pharmacol Sin; 2023 Nov; 44(11):2139-2150. PubMed ID: 37488425
[TBL] [Abstract][Full Text] [Related]
14. Histone Demethylase Modulation: Epigenetic Strategy to Combat Cancer Progression.
Srivastava R; Singh R; Jauhari S; Lodhi N; Srivastava R
Epigenomes; 2023 May; 7(2):. PubMed ID: 37218871
[TBL] [Abstract][Full Text] [Related]
15. JMJD family proteins in cancer and inflammation.
Manni W; Jianxin X; Weiqi H; Siyuan C; Huashan S
Signal Transduct Target Ther; 2022 Sep; 7(1):304. PubMed ID: 36050314
[TBL] [Abstract][Full Text] [Related]
16. Towards the simulation of large scale protein-ligand interactions on NISQ-era quantum computers.
Malone FD; Parrish RM; Welden AR; Fox T; Degroote M; Kyoseva E; Moll N; Santagati R; Streif M
Chem Sci; 2022 Mar; 13(11):3094-3108. PubMed ID: 35414867
[TBL] [Abstract][Full Text] [Related]
17. The critical role of histone lysine demethylase KDM2B in cancer.
Yan M; Yang X; Wang H; Shao Q
Am J Transl Res; 2018; 10(8):2222-2233. PubMed ID: 30210666
[TBL] [Abstract][Full Text] [Related]
18. Small molecule KDM4s inhibitors as anti-cancer agents.
Lin H; Li Q; Li Q; Zhu J; Gu K; Jiang X; Hu Q; Feng F; Qu W; Chen Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):777-793. PubMed ID: 29651880
[TBL] [Abstract][Full Text] [Related]
19. Autochthonous tumors driven by
McBrayer SK; Olenchock BA; DiNatale GJ; Shi DD; Khanal J; Jennings RB; Novak JS; Oser MG; Robbins AK; Modiste R; Bonal D; Moslehi J; Bronson RT; Neuberg D; Nguyen QD; Signoretti S; Losman JA; Kaelin WG
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3741-E3748. PubMed ID: 29610306
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
